Champions Oncology Inc (CSBR) — Cash Flow Reinvestment Rate

Latest as of July 2025: 0.15x

Champions Oncology Inc (CSBR) has a Cash Flow Reinvestment Rate of 0.15x as of July 2025, reinvesting $92.00K (capex $46.00K plus investments $-46.00K) from operating cash flow of $600.00K. See cash generation quality of Champions Oncology Inc to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

0.15x
(Capex + Investments) / Operating CF

Total Reinvested

$92.00K
Capex + Investments

Operating Cash Flow

$600.00K
USD

Capital Expenditures

$46.00K
USD

Champions Oncology Inc Cash Flow Reinvestment Rate (1997–2025)

Historical reinvestment intensity for Champions Oncology Inc across 10 annual periods. For the full cash flow conversion analysis, see Champions Oncology Inc (CSBR) cash conversion ratio.

Annual Cash Flow Reinvestment Rate for Champions Oncology Inc (1997–2025)

Year-by-year capital reinvestment analysis for Champions Oncology Inc. See Champions Oncology Inc free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2025 0.11x $778.00K $7.39 Million $389.00K ▼ -92.7%
2023 1.45x $5.74 Million $3.96 Million $2.87 Million ▲ +97.9%
2022 0.73x $4.77 Million $6.50 Million $2.38 Million ▼ -52.0%
2020 1.53x $4.44 Million $2.90 Million $2.22 Million ▲ +70.6%
2019 0.90x $1.67 Million $1.86 Million $834.00K
2008 0.00x $0.00 $792.40K $0.00 ▼ -100.0%
2001 0.23x $33.72K $144.68K $33.72K ▲ +156.4%
1999 0.09x $10.00K $110.00K $10.00K ▲ +90.9%
1998 0.05x $20.00K $420.00K $20.00K ▼ -47.6%
1997 0.09x $10.00K $110.00K $10.00K
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow